L’Autorité de la concurrence plaide pour l’ouverture du monopole des pharmacies et l’assouplissement des règles de vente en ligne.
Toujours plus d'économies. Pour 2019, l'Assurance-maladie vise un effort de 2 milliards d'euros. Il ne s'agit pas d'une réduction nette des...
Opinion: It’s time for Canada to grow up and to purge the defeatist parasitism that sometimes characterizes our policy-making
Health and Human Services Secretary Alex Azar testifies at a Senate Finance Committee hearing on prescription drug pricing.
Point-of-Sale Rebates, Copay Accumulators, and a Trump Proposal As drug prices fall under increased scrutiny, payers and regulators are tar...
Drugmakers and payers are still figuring out what data are needed to support a new wave of pricing agreements and how to collect that information earlier.
Since brand-name Truvada was approved for HIV prevention six years ago, its average wholesale price has increased by about 45 percent.
Several top drugmakers have decided to raise prices this month, a few days after a plea from Health and Human Services Secretary Alex Azar for restraint.